Skip to content
OpenCapital
Get started

Senti Biosciences SNTI Q3 2025 earnings

Reported November 13, 2025 · Before market open

EPS-$0.69Miss by $0.10
Revenue estimate$250.0K
EPS estimate-$0.59

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$14.9K
EPS estimate-$0.33

Versus estimates

Revenue

Q1 2026$16.0KQ4 2025$22.0KMiss by $978.0KQ4 2024$5.9MBeat by $3.1M

Diluted EPS

Q1 2026-$0.36Miss by $0.09Q4 2025-$0.38Beat by $0.05
Q3 2025-$0.69Miss by $0.10
Q2 2025-$0.56Beat by $0.34Q1 2025-$1.41Miss by $0.83Q4 2024-$0.67Beat by $2.46

Ask the moment Senti Biosciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Senti Biosciences report Q3 2025 earnings?
Senti Biosciences (SNTI) reported Q3 2025 earnings on November 13, 2025 before market open.
What were Senti Biosciences's Q3 2025 revenue and EPS?
Senti Biosciences reported eps of $-0.69 for Q3 2025.
Did Senti Biosciences beat estimates in Q3 2025?
EPS missed the consensus estimate of $-0.59 by $0.10.
How did Senti Biosciences's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 89.1% from $-6.31.
Where can I find Senti Biosciences's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-052083) and the 10-Q periodic report (0001628280-25-052125) directly on SEC EDGAR. The filing index links above go to sec.gov.